HALOZYME THERAPEUTICS, INC. - 10-Q Filing
Halozyme Therapeutics reports Q3 2026 financial results including revenue from proprietary products and collaborative agreements.
Tickers: $HALO
More Regulatory news
- LiveRamp Holdings, Inc. - 10-Q Filing
- Presurance Holdings, Inc. - 8-K Filing
- EXPEDITORS INTERNATIONAL OF WASHINGTON INC - 8-K Filing
- AUDIOEYE INC - 10-Q Filing
- ROCKWELL AUTOMATION, INC - 10-K Filing
- United KSK Corp - 10-Q Filing
- AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing
- VIVIC CORP. - 10-K Filing
- WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing
- BlueOne Technologies, Inc. - 10-Q Filing